Jim Simons's position in Novartis AG is currently worth $295M. That's 0.38% of their equity portfolio (37th largest holding). The first Novartis AG trade was made in Q3 2013. Since then Jim Simons bought shares 27 more times and sold shares on twenty occasions. The stake costed the investor $190M, netting the investor a gain of 55% so far.